Stable and potent polyvalent anthrax toxin inhibitors: raft-inspired domain formation in liposomes that contain PEGylated lipids.

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

Who cites it

5 citing papers in PubMed.

1. A Novel Antifungal System With Potential for Prolonged Delivery of Histatin 5 to Limit Growth ofFrontiers in microbiology · 2019
   Article
2. Cationic PAMAM dendrimers as pore-blocking binary toxin inhibitors.Biomacromolecules · 2014
   Article
3. Obstructing toxin pathways by targeted pore blockage.Chemical reviews · 2012
   Review
4. A review on composite liposomal technologies for specialized drug delivery.Journal of drug delivery · 2011
   Article
5. Enhancing protein stability by adsorption onto raftlike lipid domains.Journal of the American Chemical Society · 2009
   Article

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

Authors and funding

5 authors.

Funding

Abstract

PubMed holds no abstract for this paper.

Indexed as